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NZB X NZWFl hybrid (NZB X W Fl) mice spontaneously develop a disease that
closely resembles systemic lupus erythematosus (SLE) l in humans (1, 2) . The char-
acteristic immunologic abnormalities of these mice are the formation of diverse
antibodies reactive with native or altered autologous antigens and immune complex
(IC) glomerulonephritis (GN ; 1-4) .
The involvement of endogenous retrovirus-related antigens in murine SLE is a
long-standing theory . In support is documentation that the major envelope glycopro-
tein, gp70, is preferentially expressed in sera of NZB X W Fl mice (5-7) and is also
found in IC deposits within their diseased glomeruli (4, 5) . Retroviral gp70-anti-gp70
IC also become apparent in the circulation close to the onset of disease and their
concentrations rise with the progression of nephritis (8), constituting good evidence
that gp70-anti-gp70 IC are a potential source of renal injury . Additionally, the
participation of DNA-anti-DNA IC in the pathogenesis of murine SLE was demon-
strated when significant concentrations of anti-DNA antibodies were found in renal
eluates of NZB XW F l mice (2, 4) . The induction of tolerance to DNA in these mice
delayed the development ofanti-DNA antibodiesand renal disease (9, 10), supporting
the pathologic importance ofDNA-anti-DNA IC in murine SLE .
Evidence isnow accumulating that many individual autoimmune traits ofthe NZB
X W F l mice may be determined by single genes or gene clusters segregating
independently of each other (11-13) . Analysis of the F2 generation born of mating
between several SLE-prone strains and normal mice yielded relatively little relation-
ship among their various immunologic abnormalities such as IgM, anti-single-
stranded DNA (ssDNA) antibodies, and anti-nuclear antibodies, suggesting indepen-
dent segregation of the responsible genes (13) . The F2 generation proves to be an
excellent subject for studying which immunologic abnormalities most closely relate to
the development of renal disease in SLE-prone mice . We have now examined
individual F2 offspring ofNZB X W mice to determine whether the development of
fatal GN is associated with the presence of circulating antibodies to double-stranded
DNA (dsDNA), ssDNA, or serum gp70 . Our results indicate that in NZB X W F2
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mice, fatalGN correlates well with thepresence of antibodies to serum gp70 measured
as gp70-containing IC, but shows no significant association with free anti-DNA
antibodies .
Materials and Methods
Mice. NZB and NZW mice were originally obtained from the Laboratory Animals Centre,
Medical Research Council, Surrey, England, and since 1965 have been maintained by brother-
sister matings at Scripps Clinic and Research Foundation . NZB XW F, and F2 mice were bred
in our animal colony, and only female mice were used in this study . Their blood samples were
collected by orbital sinus puncture, and the sera were stored at -20°C until used .
Detection ofAnti-dsDNA and Anti-ssDNA Antibodies. Serum dsDNA- and ssDNA-binding activ-
ities were determined by using a modification of the Farr DNA-binding radioimmunoassay
(14) . dsDNA and ssDNAwere labeled with
1251 by the method ofCommerford (15).'251-dsDNA
was further treated with Sl nuclease (Miles Laboratories, Inc., Elkhart, Ind.) to remove single-
stranded regions within dsDNA preparations (16) . The purity of the '251-labeled dsDNA was
tested by using murine antibodies specific for ssDNA but not dsDNA. These antibodies
precipitated <5% of the radioactivity. The results are expressed as a percentage of the 20 ng of
I25I-DNA precipitated specifically after correction for nonspecific precipitation in pooled sera
from five different strains of normal mice . Values of dsDNA-binding activity higher than 2 SD
values (7.5%) for the mean level of 8-mo-old NZW mice were considered positive . More than
30% ssDNA-binding activity was regarded as positive. The immunoglobulin class of anti-DNA
antibodies was analyzed by sucrose density gradient ultracentrifugation (17) . The quantities of
anti-DNA antibodies in sera and renal eluates (8) were determined by a solid-phase radioim-
munoassay similar to that described for IgG anti-human gammaglobulin antibodies (18) .
Radioimmunoassays for Circulating DNA-anti-DNA IC and DNA . The presence of circulating
DNA-anti-DNA IC was examined according to a modification (17) of the method of Harbeck
et al . (19) . In this assay, serum DNA-binding activity was measured before and after treatment
of sera with DNase, which liberates anti-DNA antibodies bound to DNA, resulting in the
increase of DNA-binding activity .
The amounts of DNA in sera were determined by inhibiting the binding of 1251-ssDNA to
anti-DNA antibodies as previously described (17, 20) . The specificity ofthe assay was controlled
by DNase treatment of the samples . Because anti-DNA antibodies might interfere with the
digestion ofDNA by DNase, samples were pretreated for 30 min at room temperature with0.5
N HCI, which not only dissociates DNA-anti-DNA IC but also abolishes anti-DNA activities .
Further, this HCI treatment of DNA increases its binding affinity to anti-DNA antibodies .
Quantitation of Circulating Antibodies to Serum gp70.
￿
Because of the great excess of gp70 in sera,
free antibodies reactive with serum gp70 were not detectable . Therefore, serum levels of anti-
gp70 antibodies were expressed as the concentrations of gp70 bound to anti-gp70 antibodies .
To determine the serum concentrations ofantibody-bound gp70, 0.05 ml of serum was layered
on 5-20% (wt:vol) linear sucrose gradients in 0.01 M phosphate-buffered saline, pH 7.0, and
centrifuged at 32,000 rpm for 16 h at 4°C in a Beckman L-75 ultracentrifuge with a SW60
rotor (Beckman Instruments, Inc., Fullerton, Calif.) . The positions of IgM, IgG, or gp70 were
established by radioactive markers, and the gradients were divided into 14 fractions . Each
fraction was radioimmunoassayed for the presence of gp70 . Because IgG and gp70 peaked in
the 10th and 12th fractions, respectively, gp70 present in the first eight fractionswasconsidered
a rapidly sedimenting, heavy form ofantibody-bound gp70 . From the gp70 content ofthe first
eight fractions, serum levels of heavy antibody-bound gp70 were computed . Values of 3 SD or
more above the mean level of 8-mo-old NZW mice were considered positive.
Renal Pathology .
￿
Renal tissues ofNZB XWF2 mice were obtained at autopsy, processed for
histologic examination, and stained with hematoxylin and eosin or periodic acid-Schiff. GN
was quantitated on a 0-4+ scale based on the intensity and extent of histopathologic changes
(21) . A grade of 0 was given to kidneys without glomerular lesions. 1+ lesions corresponded to
minimal thickening of the mesangium ; 2+ lesions contained noticeable increases in both
mesangial and glomerular cellularity ; 3+ lesions were characterizedby the preceding conditions
with superimposed inflammatory exudates and capsular adhesions; and in 4+ lesions, theglomerular architecture was obliterated in >70% of glomeruli, and tubular cast formation was
extensive . Grades 3 and 4 GN were considered significant contributors to clinical disease
and/or death .
Statistical Analysis .
￿
Methods of statistical analysis included the X2 test, the linear correlation
analysis, and the Wilcoxon two-sample test . Probability values of >5% were considered
insignificant .
Mortality with GN.
￿
Fig . 1 documents the cumulative mortality of glomerulone-
phritic NZB, NZW, NZB X W Fl, and F2 female mice . NZB X W Fl and F2 mice
began dying of renal disease at 5 mo ofage, and their 50% mortality points were 8 mo
and 11 mo, respectively . However, their parental strains, NZB and NZW mice,
developed fatal GN much later in life and did not begin dying until 9 and 13 mo of
age, respectively . 50% of NZB mice and <20% ofNZW mice died of renal disease by
15 mo of age .
Anti-DNA and the Heavy Form of Antibody-bound gp70 in Sera of NZB, NZW, and NZB
X W Fr, and Fa Mice. Anti-dsDNA antibodies developed relatively late compared
with anti-ssDNA antibodies in all four kinds of mice . NZB X W F l had the highest
levels of both anti-dsDNA and anti-ssDNA antibodies, andNZW mice had the lowest
during the entire course of experimentation . Amounts of antibodies to both dsDNA
and ssDNA in the sera of NZB X W F2 mice were similar to those in NZB mice .
Representative results of serum dsDNA- and ssDNA-binding activities at 8 mo of age
are shown in Table I .
The antibody-bound, heavy form of retroviral gp70 became obvious in the sera of
NZB XW Fl and F2 mice at ^-4mo of age . Moreover, the incidence and concentrations
increased with the progression of disease . At 8 mo ofage, the mean values were highest
in NZB X W Fl mice (Table I) . In fact, 19 of 20 NZB XW Fl mice were positive, i.e .,
exceeded the mean level of 8-mo-old NZW mice by at least 3 SD . Approximately half
(33 of 72) of the NZB XW F2 mice had significant amounts of anti-gp70-bound gp70
IC in their sera . Only 5 of 20 NZB and none of 20NZW mice tested developed these
gp70 complexes. Although the frequency and quantitites of antibody-bound gp70 in
sera were very different among these four kinds of mice, their serum concentrations of
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TABLE I
Serum Levels ofAntibodies to dsDNA and ssDNA and Complexes ofgp70
Bound to Anti-gp70 Antibodies in NZB, NZW, NZB X W F,, and F2
Female Mice
All values were determined when mice were 8 mo of age .
* Percent binding of 20 ng 126I-dsDNA by 10 ttl serum .
$ Percent binding of 20 ng ,2eI-ssDNA by 5 Id serum .
§ Micrograms per milliliter of the heavy form of anti-gp70 complexed gp70 in
serum .
TABLE II
Association between Anti-dsDNA and Anti-ssDNA Antibodies in 8-mo-old
NZB X WF2 Mice
X
2 =20.01;P<0.001 .
total amounts of gp70 (free and complexed) were similar : NZB, 49.0 ± 18.6 g,g/ml ;
NZW, 41 .1 ± 11 .5 Ftg/ml ; NZB X W Fl , 43.4 ± 18.0 lug/ml ; and NZB X W F2,41 .2
± 19.4 tLg/ml .
Relationship amongAnti-dsDNA, Anti-ssDNA, andAnti-gfi70-boundgp70 in NZB X W F2
Mice. To determine whether a correlation existed among anti-dsDNA, anti-ssDNA,
and antibody-bound gp70, the sera from 72 individual 8-mo-old NZB X W F2 mice
were analyzed for the three components. There was a notable association between
anti-dsDNA and anti-ssDNA antibodies (?C2 = 20.01, P < 0.001 ; Table II) . In fact,
when individual values for anti-dsDNA and anti-ssDNA antibodies were compared,
the correlation was highly significant (r = 0.708, P< 0.001) .
In contrast, there was a very weak association between the presence ofanti-dsDNA
antibodies and anti-gp70-bound gp70 complexes (X2 = 4.47, P< 0.05 ; Table III) . No
relationship was observed between anti-ssDNA antibodies and antibody-bound gp70
IC (X ,2 = 0.70, P > 0.1 ; Table IV) .
Lack of Association between Anti-DNA Antibodies and Fatal GN in NZB X W F2
Mice. We next examined which serum components bore a relationship to the
development of fatal GN in NZB X W F2 females . For this purpose, the presence of
anti-dsDNA, anti-ssDNA, and antibody-bound gp70 IC in sera of mice up to 8 mo of
age was analyzed relative to the development of fatal GN up to 15 mo. Death from
GN did not correlate with positivity for either serum dsDNA-binding activity or
ssDNA-binding activity measured in 8-mo-old animals (Tables V and VI) . Further-
more, mean values of serum dsDNA- and ssDNA-binding activities were essentially
Mice Number Anti-dsDNA* Anti-ssDNA$
Anti-gp70
IC§
NZB 20 6.0 ± 3.9 30 .7 ± 14 .5 2 .6 ± 3 .0
NZW 20 3.5±2.0 16.1±7 .3 1 .0±0.8
NZBXWF, 20 11.1±6.7 48.4±12 .5 15.2±11 .4
NZBXWF2 72 6.6±10.8 28.1±19 .7 5.9±7.9
Anti-dsDNA
Anti-ssDNA
Positive Negative
Total
Positive 21 0 21
Negative 20 31 51
Total 41 31 72IZUI ET AL.
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TABLE III
Weak Association between Anti-dsDNA Antibodies and Anti-gp701C in
8-mo-old NZB X W F2 Mice
X
2 =4.47;PG0.05.
TABLE IV
Lack ofAssociation between Anti-ssDNA Antibodies and Anti-gp70 IC in
8-mo-old NZB X W F2 Mice
Age
X2 =0.70; P>0.1.
TABLE V
Lack ofAssociation between Anti-dsDNA Antibodies and Fatal GN in
NZB X W F2 Mice
Anti-dsDNA
Positive* Negative*
* Based on the results oftesting 8-mo-old mice.
X
2 P
identical in the group of mice that died from fatal GN and those that survived up to
15 mo (Fig. 2) .
The immunoglobulin classes of anti-ssDNA antibodies were also compared in mice
with or without fatal GN by determining the ssDNA-binding activity of IgM and IgG
peaks in gradient fractions resulting from ultracentrifugation. Again, there were no
differences between these two groups of mice (IgM anti-ssDNA; GN group, 10.0 :L-
7.6%; no-GN group, 8.8 ± 7.1%; IgG anti-ssDNA; GN group, 24.0 ± 20.9%; no-GN
group, 24.1 ± 22.7%).
To seek the possible presence of DNA-anti-DNA IC in the sera of NZB X W F2
mice with or without GN, serum dsDNA- and ssDNA-binding activities were evalu-
ated before and after treatment of sera with DNase, which liberates anti-DNA
mo
Fatal
GN
Surviv-
ing
Fatal
GN
Surviv-
ing
8 3 18 6 45 0.01 >0.9
10 7 14 10 41 0.89 >0.1
12 8 13 12 39 0.93 >0.1
15 12 9 17 34 2.59 >0.1
Anti-gp70 IC
Anti-ssDNA
Positive Negative
Total
Positive 17 9 26
Negative 24 22 46
Total 41 31 72
Anti-gp70 IC
Anti-dsDNA
Positive Negative
Total
Positive 12 14 26
Negative 9 37 46
Total 21 51 72522
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TABLE VI
Lack ofAssociation between Anti-ssDNA Antibodies and Fatal GN in
NZB X W F2 Mice
Age
* Based on the results of testing 8-mo-old mice.
m
z
40,
Anti-dsONA
0-
Positive* Negative*
Anti-ssDNA
.yw.
GN
￿
No GN
60
Anti-ssDNA
X
2 P
FIG. 2.
￿
Serum dsDNA- and ssDNA-binding activities of 8-mo-old NZB X W F2 female mice. GN:
group ofmice that died of fatal GN by 15 mo of age. No GN: group of mice surviving at 15 mo of
age. The mean values are indicated by the horizontal line.
antibodies from DNA-anti-DNA IC, resulting in the increase of serum DNA-binding
activity (19) . However, none of the sera from either group of mice increased signifi-
cantly in dsDNA- or ssDNA-binding activity after the DNase treatment (data not
shown) .
Association between Antibody-bound gp70 IC and Fatal GN in NZB X W F2 Mice.
￿
Unlike
anti-DNA antibodies, antibody-complexed gp70 levels tested at 8 mo of age were
significantly higher (7.1 ± 7 .8 leg/ml) in mice with early fatal GN than in mice that
lived up to 15 mo (2.2 ± 2.7 l-Lg/ml; P < 0.001) (Fig. 3) . Nevertheless, serum levels of
total gp70 (free and complexed) were nearly identical in both groups of mice (Fig. 3) .
Table VII shows a significant and consistent association between the presence of
antibody-bound gp70 IC and the development of fatal GN throughout the test period
(8-15 mo of age). In fact, 19 of 26 NZB X W F2 mice with anti-gp70 IC by 8 mo of
age developed fatal GN by 15 mo, but only 10 of 46 mice without anti-gp70 IC at 8
mo ofage died ofrenal disease. It should be noted that 8 ofthe 10 mice that developed
GN became positive for anti-gp70 IC in a few months before death, i.e., before 12 mo
mo
Fatal
GN
Surviv-
ing
Fatal
GN
Surviv-
ing
8 5 36 4 27 0.03 >0.9
10 9 32 8 23 0.06 >0.9
12 10 31 10 21 0.39 >0.5
15 15 26 14 17 0.48 >0.5MO.
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* Based on the results of testing 8-mo-old mice.
Total gp70
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￿
No GN
￿
I
￿
GN
￿
No GN
FiG. 3.
￿
Serum levels of total gp70 and the heavy form of antibody-complexed gp70 in 8-mo-old
NZB X W F2 female mice. The mean values are indicated by the horizontal line. The dotted line
indicates the mean value of 8-mo-old NZW females plus 3 SD.
TABLE VII
Association between Anti-gp70 IC and Fatal GN in NZB X W FZ Mice
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of age, whereas only 11 of 36 other mice had significant amounts of anti-gp70 IC by
12
Table VII also reveals that all nine mice that died by 8 mo of age had significant
amounts of anti-gp70 IC in their sera, but sera from four of these nine mice were not
abnormal in the capacity to bind either dsDNA or ssDNA (Tables V and VI) . When
we extended testing for antibody-bound gp70 and anti-DNA antibodies until the
animals were 15 mo of age, 9 of 29 NZB X W FZ mice that died of GN did not
develop significant amounts of antibodies to dsDNA or ssDNA, and only 2 did not
have significant levels of anti-gp70 IC in their sera. It should be noted that production
of anti-DNA antibodies was also negligible in these two mice, although they died of
severe GN (grade 4+) . The possibility that the presence of free or antibody-bound
DNA might affect the detection of antibodies in these nine mice was excluded by the
fact that no detectable amounts of free or antibody-bound DNA (<0.5 [Lg/ml) were
found in sera throughout the entire course of their life.
The amounts of anti-DNA antibodies elutable from the kidneys were compared
between the groups of mice developing fatal GN with high or low levels of anti-DNA
antibodies in sera. Considerable amounts of anti-DNA antibodies were demonstrable
Age
mo
Positive*
Fatal GN Surviving
Negative*
Fatal GN Surviving
X
2 P
8 9 17 0 46 14.72 <0.001
10 14 12 3 43 17.55 <0.001
12 16 10 4 42 19.96 <0.001
15 19 7 10 36 15.66 <0.001
IC
30,
Anti-gp70
70-
E 20_
i
E 50- 0 h a524
￿
gp70 IMMUNE COMPLEXES IN MURINE LUPUS NEPHRITIS
in renal eluates of mice with high serum levels ofanti-DNA antibodies (4.12 Ftg/g of
tissue), which were approximately seven times greater than in renal eluates from mice
with low serum levels ofanti-DNA antibodies (0.67 l g/g of tissue) . The quantities of
anti-DNA antibodies elutable from the kidneys were 3.2 and 1 .4% of total IgG
recovered from the kidneys, respectively, and concentrations were ^-10 times greater
than in the serum .
Discussion
We have analyzed the development of fatal GN in the F2 generation ofNZB X W
mice relative to the presence of circulating antibodies to serum retroviral gp70,
dsDNA, and ssDNA . The quantity of anti-gp70 antibodies, determined by measuring
amounts of the heavy form of antibody-bound gp70 (the complexed form), correlated
significantly with the development of fatal GN . In contrast, no significant association
was observed among the presence of antibodies to dsDNA or ssDNA and fatal GN .
Apparently, circulating IC containing gp70 and anti-gp70 antibodies were indicators
of early fatal GN .
The equivalent titer of anti-dsDNA and anti-ssDNA antibodies in 8-mo-old NZB
X W F2 mice suggests that the appearance of both types ofanti-DNA antibodies may
be regulated by at least one common control mechanism . Of course, one cannot
exclude the fact that the correlation observed between anti-dsDNA and anti-ssDNA
antibodies may have resulted from the cross-reactivity of anti-ssDNA antibodies to
1251-dsDNA, although potential contaminants from the single-stranded regions within
the 1251-dsDNA preparation were removed by the treatment with single-strand specific
Sl nuclease (14, 16) . Afterward, the reactivity o£ 1251-dsDNA to mouse antibodies
specific for ssDNA was <5% . Still, no F2 mouse had anti-dsDNA antibodies alone,
although about half of the anti-ssDNA-positive mice lacked significant anti-dsDNA
activities . Apparently, the production ofanti-ssDNA antibodies is under multifactorial
control unlike that of anti-dsDNA antibodies . In fact, in immunologically normal
strains of mice, anti-ssDNA antibodies, but not anti-dsDNA antibodies, are relatively
easy to induce as a result of polyclonal activation ofB cells by injection of bacterial
lipopolysaccharides or infection with certain parasites (20, 22-24) . The simultaneous
appearance of polyclonal anti-hapten antibodies and anti-ssDNA antibodies in all the
SLE-prone mice (25) suggests that the comparatively early appearance ofanti-ssDNA
antibodies may, at least partly, be related to polyclonal B cell activation .
The production of antibodies to serum retroviral gp70 did not correlate well with
that of anti-DNA antibodies . There was no relationship at all between the presence
of antibody-bound gp70 and anti-ssDNA antibodies in sera from NZB XW F2 mice,
although anti-gp70 production was weakly associated with anti-dsDNA antibody
formation . Of course, one should interpret these results cautiously, because several
factors, e.g., mononuclear phagocytic activity, may influence serum levels ofanti-gp70
antibodies complexed with gp70 without affecting the levels of free anti-DNA
antibodies . However, anti-DNA and anti-gp70 antibody production were also unre-
lated in SLE-prone mice treated with prostaglandin E1 (PGE) or infected with lactic
dehydrogenase virus (LDV) . PGE treatment greatly reduced serum levels of anti-
gp70-complexed gp70 without affecting serum DNA-binding activities (26), and
infection with LDV suppressed anti-DNA antibody production without changing
serum levels of antibody-bound gp70 IC (S . Izui, L Hang, P.J . McConahey, and F . J .IZUI ET AL .
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Dixon, manuscript in preparation) . Apparently, the antibody response to DNA
antigens is regulated independently from that to serum retroviral gp70 antigen . If so,
undoubtedly the gene(s) responsible for the production of anti-gp70 antibodies is
segregated from that governing anti-DNA antibody formation in the F2 generation of
NZB XW mice . This possibility is further supported by recent findings is recombinant
inbred strains between NZB and ALN mice, that individual traits of an autoimmune
phenotype are inherited independently (12) .
A significant observation in the present study was that the development of fatal
GN in NZB X W F2 mice correlates notably with the presence of circulating anti-
gp70 IC . Generally, antibody-complexed gp70 IC in sera become detectable several
months before the mice developed fatal renal disease and increased numerically as
the disease worsened . Thus, one could predict the course of renal disease by determin-
ing the serum levels of anti-gp70 IC . Because both NZB andNZW strains express the
same kind of retroviral gp70 in sera at equally high levels, and only NZB and NZB
XW F l mice develop antibody-complexed gp70 (8, 26-29), the gene(s) responsible for
the formation of circulating anti-gp70 IC should be the gene(s) that determines or
regulates the production of anti-gp70 antibodies . Consequently, this could be one of
the major genes for GN segregated in the F2 generation ofNZB X W mice .
In contrast, neither anti-dsDNA or anti-ssDNA antibodies are associated with the
development of fatal GN in NZB X W F2 mice . In fact, neither titers nor incidences
of these anti-DNA antibodies were significantly different in mice developing early
fatal GN and those surviving up to 15 mo of age . Although the qualitative aspects of
the anti-DNA-response in murine SLE may be equally important in provoking renal
disease, we found no differences in the isotypes ofserum anti-DNA antibodies between
the short-lived group of mice and the survivors. Of particular interest is the fact that
four of nine mice that died of renal disease before 8 mo of age did not have either
anti-dsDNA or anti-ssDNA antibody activities detectable in their sera, whereas all
nine micehad substantial amounts ofanti-gp70 antibodies in complexes . The presence
of free DNA might account for the failure to demonstrate anti-DNA antibodies in
these mice ; however, no detectable amounts of DNA could be demonstrated in these
mouse sera, even at the terminal stage of their disease . Furthermore, the fact that
none of the sera had rapidly sedimenting (heavy) anti-DNA complexes argues against
the presence ofDNA-anti-DNA IC in these mice . Although there issome disagreement
as to the effectiveness of DNase treatment in the liberation of anti-DNA antibodies
from IC (19, 30, 31), none of these sera showed an increased binding to dsDNA or
ssDNA after treatment with DNase.
It is noteworthy that significant amounts of anti-DNA antibodies were elutable
from the glomerulonephritic kidneys of mice without abnormally high levels of anti-
DNA antibodies in sera, although their quantities were much lower than those from
mice with high anti-DNA antibodies . This supports the involvement of anti-DNA
antibodies in murine lupus nephritis . It should be emphasized that the amounts of
anti-DNA antibodies recoverable from kidneys and the amounts of anti-gp70 anti-
bodies in the kidneys estimated from the eluted gp70 (antigen/antibody = 2) together
account for less than half the total elutable Ig .
Our observations strongly suggest that circulating anti-gp70 IC are a potential
source of renal injury in SLE-prone mice . However, anti-gp70 IC are not the only
cause ofGN, because 2 of 29 mice that died ofsevere GN (grade 4+) had neither anti-526
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DNA antibodies nor anti-gp70 IC in their sera to any significant degree. Certainly,
unknown kinds of IC may be involved in the pathogenesis of GN in murine SLE. In
fact, unidentified IC-like materials have been found in sera of SLE-prone mice by
several kinds of assays (4, 32, 33) . Nevertheless, the present study clearly shows that
anti-gp70-complexed gp70 is a useful and predictive indicator of murine lupus
nephritis.
Summary
NZB X NZW (NZB X W) Fl hybrid mice spontaneously develop a disease most
prominently characterized by immune complex glomerulonephritis (GN), which
seems to be associated with both antibodies to DNA and to the serum retroviral
envelope glycoprotein, gp70. To evaluate the contribution of each of these autoim-
mune responses to the pathogenesis of the GN, we studied NZB X W F2 mice in
which the two responses appeared to segregate relatively independently. Use of this
model permitted analysis of possible correlations between each response and the GN.
The presence of circulating anti-gp70-complexed gp70 correlated significantly with
the development of fatal GN and one could predict the course of renal disease by
computing the rising serum levels of gp70 complexed with antibodies. In contrast, the
presence of free antibodies to either double-stranded or single-stranded DNA was not
significantly associated with the development of fatal GN. This association of anti-
gp70 antibody production with these animals' early death from GN strongly suggests
that the gene(s) governing production of antibodies to serum retroviral gp70 may be
one of the major genes responsible for spontaneous renal disease segregated in NZB
X W F2 generations.
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